€9.70
1.67% today
Madrid, Apr 02, 05:35 pm CET
ISIN
ES0157097017
Symbol
ALM
Sector
Industry

Almirall Stock price

€9.70
-0.19 1.92% 1M
+0.72 7.96% 6M
+1.46 17.73% YTD
+1.57 19.25% 1Y
-1.95 16.71% 3Y
-1.00 9.31% 5Y
-7.14 42.43% 10Y
Madrid, Closing price Wed, Apr 02 2025
-0.17 1.67%
ISIN
ES0157097017
Symbol
ALM
Sector
Industry

Key metrics

Market capitalization €2.10b
Enterprise Value €2.12b
P/E (TTM) P/E ratio 202.05
EV/FCF (TTM) EV/FCF 16.64
EV/Sales (TTM) EV/Sales 2.15
P/S ratio (TTM) P/S ratio 2.14
P/B ratio (TTM) P/B ratio 1.41
Dividend yield 1.87%
Last dividend (FY24) €0.18
Revenue growth (TTM) Revenue growth 10.20%
Revenue (TTM) Revenue €985.72m
EBIT (operating result TTM) EBIT €46.17m
Free Cash Flow (TTM) Free Cash Flow €127.22m
EPS (TTM) EPS €0.05
P/E forward 43.35
P/S forward 1.91
EV/Sales forward 1.92
Show more

Is Almirall a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,807 stocks worldwide.

Almirall Stock Analysis

Unlock Scores for Free

Analyst Opinions

12 Analysts have issued a Almirall forecast:

12x Buy
100%

Analyst Opinions

12 Analysts have issued a Almirall forecast:

Buy
100%

Financial data from Almirall

Income Statement P&L | Balance Sheet | Cash Flow


TTM Annually
Dec '24
+/-
%
986 986
10% 10%
100%
- Direct Costs 592 592
9% 9%
60%
394 394
13% 13%
40%
- Selling and Administrative Expenses 129 129
12% 12%
13%
- Research and Development Expense 79 79
18% 18%
8%
185 185
11% 11%
19%
- Depreciation and Amortization 139 139
12% 12%
14%
EBIT (Operating Income) EBIT 46 46
9% 9%
5%
Net Profit 10 10
126% 126%
1%

In millions EUR.

Don't miss a Thing! We will send you all news about Almirall directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Almirall SA is a global biopharmaceutical company, which is focused on skin health. It engages in the development, manufacture, storage, commercialization and sale of pharmaceutical and cosmetic products, as well as of the raw materials used in production. The firm operates through the following segments: Marketing through Own Network, Marketing by Licensees, Research and Development Activity, Therapeutic Area of Dermatology in the United States, and Corporate Management and Results not Allocated Assigned to Other Segments. Its products include treatments for respiratory, autoimmune, dermatological, and gastrointestinal diseases. The company was founded in 1943 and is headquartered in Barcelona, Spain.

Head office Spain
CEO Carlos Piqué
Employees 2,026
Founded 1995
Website www.almirall.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today